SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-24-000150
Filing Date
2024-04-29
Accepted
2024-04-29 16:07:21
Documents
16
Period of Report
2024-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgbp042924form8k.htm   iXBRL 8-K 25043
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 10288
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 3170
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 4218
  Complete submission text file 0001607062-24-000150.txt   220514

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE rgbp-20240426.xsd EX-101.SCH 3254
6 XBRL LABEL FILE rgbp-20240426_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE rgbp-20240426_pre.xml EX-101.PRE 22377
19 EXTRACTED XBRL INSTANCE DOCUMENT rgbp042924form8k_htm.xml XML 3671
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 24890666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)